Abstract
A possible strategy to promote the wound-healing cascade in both soft and hard tissues is the preparation of an autologous platelet-rich plasma (PRP) to encourage the release of growth factors from activated platelets. In this process, PRP combines the advantage of an autologous fibrin clot that will aid in hemostasis as well as provide growth factors in high concentrations to the site of a tissue defect. The PRP preparation can be used as a biological enhancer in the healing of fractures and lumbar fusions. The local application of growth factors seems to promote initiation and early maturation of bone formation. Autologous bone or bone substitutes can be added to this mixture to increase the volume of grafting material. A simplified technique utilizing a commercially available separation system (GPS—Gravitational Platelet Separation System) is described. This system provides a less costly alternative to other previously described augmentation techniques and also presents a patient-friendly and operator-safe alternative. Further experimental studies of the actual concentrations of the growth factors in the PRP samples are necessary in order to validate the platelet concentration and growth-factor activation by laboratory evidence. In further prospective clinical trials, the safety and efficacy of PRP, in combination with autologous bone or bone graft substitutes, must be evaluated.
Similar content being viewed by others
References
Bhanot S, Alex JC (2002) Current applications of platelet gels in facial plastic surgery. Facial Plast Surg;18:27–33
Boden SD (2002) Overview of the biology of lumbar spine fusion and principles for selecting a bone graft substitute. Spine 27:S26–31
Boden SD, Kang J, Sandhu H, Heller JG (2002) Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies. Spine 27:2662–2673
Canalis E (1985) Effect of growth factors on bone cell replication and differentiation. Clin Orthop 193:246–263
Canalis E, McCarthy TL, Centrella M (1989) Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol 140:530–537
Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9:641–650
Gospodarowicz D (1983) Growth factors and their action in vivo and in vitro. J Pathol 141:201–233
Hotz G (1991) Alveolar ridge augmentation with hydroxylapatite using fibrin sealant for fixation. I. An experimental study. Int J Oral Maxillofac Surg 20:204–207
Hotz G (1991) Alveolar ridge augmentation with hydroxylapatite using fibrin sealant for fixation. II. Clinical application. Int J Oral Maxillofac Surg 20:208–213
Howes R, Bowness JM, Grotendorst GR, Martin GR, Reddi AH (1988) Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation. Calcif Tissue Int 42:34–38
Kasperk CH, Wergedal JE, Mohan S, Long DL, Lau KH, Baylink DJ (1990) Interactions of growth factors present in bone matrix with bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors 3:147–158
Lowery GL, Kulkarni S, Pennisi AE (1999) Use of autologous growth factors in lumbar spinal fusion. Bone 25:47S-50S
Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA (2001) Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24:483–488
Martinowitz U, Spotnitz WD (1997) Fibrin tissue adhesives. Thromb Haemost 78:661–666
Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR (1998) Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:638–646
Matras H (1985) Fibrin seal: the state of the art. J Oral Maxillofac Surg 43:605–611
Nielsen HM, Andreassen TT, Ledet T, Oxlund H (1994) Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 65:37–41
Nimni ME (1997) Polypeptide growth factors: targeted delivery systems. Biomaterials 18:1201–1225
Noda M, Camilliere JJ (1989) In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 124:2991–2994
Schilephake H (2002) Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31:469–484
Slater M, Patava J, Kingham K, Mason RS (1995) Involvement of platelets in stimulating osteogenic activity. J Orthop Res 13:655–663
Sonnleitner D, Huemer P, Sullivan DY (2000) A simplified technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: a technical note. Int J Oral Maxillofac Implants;15:879–882
Vaccaro AR, Anderson DG, Toth CA (2002) Recombinant human osteogenic protein-1 (bone morphogenetic protein-7) as an osteoinductive agent in spinal fusion. Spine 27:S59–65
Whitman DH, Berry RL, Green DM (1997) Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55:1294–1299
Acknowledgements
This study was supported by a grant from the Ludwig Boltzmann Society.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marlovits, S., Mousavi, M., Gäbler, C. et al. A new simplified technique for producing platelet-rich plasma: a short technical note. Eur Spine J 13 (Suppl 1), S102–S106 (2004). https://doi.org/10.1007/s00586-004-0715-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-004-0715-3